Glukoza (Glucosum Anhydricum Fp) Pph Microfarm (Glucose)

Glukoza serves as a non‑medicinal component in a variety of pharmaceutical and nutritional preparations, providing a readily absorbable source of carbohydrate.

• As a filler or diluent in oral tablets and capsules.
• As a sweetening agent in syrups, suspensions, and chewable formulations.
• To adjust osmolarity in parenteral nutrition solutions.
• As a substrate in in‑vitro diagnostic assays that require glucose.
• For compounding pediatric or geriatric formulations where rapid energy supply is needed.
• As a stabilizing carbohydrate in freeze‑dry (lyophilized) vaccine preparations.
• To support cell culture media formulations that require defined glucose concentrations.

Glukoza, when ingested as part of a formulation, generally exhibits a safety profile consistent with dietary glucose, but adverse reactions can still occur in susceptible individuals.

Common

• Mild gastrointestinal discomfort such as bloating or flatulence.
• Transient increase in blood glucose levels in individuals without diabetes.
• Slight nausea when consumed in large quantities.
• Temporary sweet taste perception leading to increased desire for sugary foods.
• Mild headache reported by some individuals after rapid glucose absorption.

Serious

• Hypersensitivity reactions including rash, itching, or urticaria.
• Severe hyperglycemia in patients with uncontrolled diabetes.
• Rare cases of anaphylaxis reported with excipient contamination.
• Potential for osmotic diarrhea when administered in high concentrations.

When incorporating Glukoza into pharmaceutical or nutritional products, several precautionary measures should be observed to ensure safety and product quality.

• Verify the glucose purity to avoid contamination with microbial or chemical impurities.
• Assess the patient’s glycemic status, especially in diabetic or pre‑diabetic populations.
• Limit the amount of Glukoza in formulations intended for infants or individuals with impaired glucose tolerance.
• Store the product in a dry, cool environment to prevent moisture uptake and clumping.
• Avoid using Glukoza in products requiring strict low‑carbohydrate content, such as ketogenic diets.
• Ensure compatibility with other excipients to prevent unexpected chemical reactions.
• Document the source and batch number for traceability in regulated manufacturing.

Glukoza may influence the performance of other substances when combined in a formulation or taken concurrently, and certain interactions warrant attention.

Avoid

• Co‑administration with high‑dose insulin or other rapid‑acting glucose‑lowering agents without medical supervision.
• Mixing with acidic excipients that can promote caramelization and alter product stability.

Use with caution

• Concurrent use with medications that have a narrow therapeutic index and are affected by blood glucose fluctuations, such as certain antiepileptics.
• Formulations containing other sugars, which may increase overall carbohydrate load and affect caloric calculations.
• Use in patients receiving parenteral nutrition where glucose infusion rates must be carefully balanced.